Neuren Pharmaceuticals dividend and valuation

NEU · ASX · AUD

Compare Neuren Pharmaceuticals
$20.97Change from previous close: −4.73%Absolute change: −$1.04

Close · November 20, 2026

Valuation

Neuren Pharmaceuticals paid $0.15 per share in dividends over the last 12 months (yield 0.7%). Last ex-dividend date: September 15, 2026. The P/E ratio is 144.0. The average price target of 6 analysts is $27.03.

Data as of November 21, 2026

Neuren Pharmaceuticals compared with similar companies

Neuren Pharmaceuticals's P/E (trailing 12 months): 144.0, +111% against the median of a group of 6 similar companies (68.2).

Neuren Pharmaceuticals's metrics compared with similar companies
MetricNeuren PharmaceuticalsMedian25th–75th percentileBand
P/E (trailing 12 months)144.068.240.5 – 95.9High
Forward P/E36.136.126.0 – 45.4Middle
EV/EBITDA180.367.630.4 – 135.7High
Price/book8.214.642.59 – 7.27High
Price/sales39.418.47.40 – 43.6Middle
Gross margin29.6%77.3%49.8% – 84.4%Low
Operating margin19.9%14.0%-18.8% – 20.5%Middle
Net margin29.1%3.8%-61.6% – 25.3%High
ROE6.2%10.4%-1.8% – 35.7%Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Neuren Pharmaceuticals: valuation over time

On the latest fiscal year's earnings (2025), Neuren Pharmaceuticals's P/E today is 90.1, above the median of its last 5 fiscal years (45.2; between 11.5 and 91.4 from 2017 to 2025). Relative to earnings, the stock costs more than it used to.

Neuren Pharmaceuticals P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/E
2025$18.61$0.2380.0
2024$12.50$1.0911.5
2023$24.97$1.2020.8
2022$7.95$0.00—
2021$3.77-$0.07—
2020$1.28-$0.09—
2019$2.48-$0.11—
2018$1.40$0.0345.2
2017$3.20$0.0391.4
2016$1.16-$0.14—

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$2.74B
Enterprise value
$2.5B
EV/revenue
36.0

Profitability and growth

ROA
2.6%
ROIC
2.6%
Revenue growth (year over year)
17.3%
Earnings growth (year over year)
-67.3%

Financial health

Total cash
$286.54M
Total debt
$0
Current ratio
46.5
Quick ratio
44.6
Altman Z-Score
172.7
Piotroski F-Score
4.00

Dividends

Annual dividend per share
$0.15
Dividend yield
0.7%
Payout ratio
100.0%
Ex-dividend date
September 15, 2026

Analysts and estimates

Average price target
$27.03
Median price target
$26.40
High price target
$29.70
Low price target
$25.90
Analysts with a price target
6
Consensus
Strong buy
Forward EPS
$0.60
EPS estimate, current year
$0.43

Shares and trading

Beta
1.59
Average volume
436.2K
Shares outstanding
126.77M
Float
109.86M
Institutional ownership
23.1%
Insider ownership
13.3%